Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Budesonide in Babies (BiB) Trial
NCT04545866Phase 3Active, not recruiting
- Sponsor
- NICHD Neonatal Research Network
- Start
- Apr 2021
- Primary completion
- Sep 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of budesonide in bronchopulmonary dysplasia (BPD) (2 arms), sponsored by NICHD Neonatal Research Network. Primary endpoint: Physiologic Bronchopulmonary Dysplasia or Death. Started Apr 2021; status: active, not recruiting.
02
Drugs
budesonide
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT04545866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04545866.